https://defencetherapeutics.com/neve-blog/ 2026-08-19T20:01:37+00:00 https://defencetherapeutics.com/uspto-grants-trademark-registration-for-defence-therapeutics/ 2023-05-29T21:54:12+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_334242430-scaled.jpeg https://defencetherapeutics.com/defences-successful-accutox-pre-clinical-efficacy-study-complete-ready-for-phase-i-and-filing/ 2023-05-29T21:54:24+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_333511912-scaled.jpeg https://defencetherapeutics.com/breakthrough-results-defences-arm-vaccine-cured-100-of-animals-with-pre-established-lymphoma/ 2023-05-29T21:54:38+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_321710772-scaled.jpeg https://defencetherapeutics.com/defence-announces-additional-and-final-exercises-of-warrants-for-gross-proceeds-of-over-2-3-million/ 2023-05-30T18:42:53+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_194483477-scaled.jpeg https://defencetherapeutics.com/defence-begins-testing-its-arm-vaccine-against-pancreatic-cancer/ 2023-06-06T16:54:26+00:00 https://defencetherapeutics.com/wp-content/uploads/2020/11/973320.jpg https://defencetherapeutics.com/defence-manufacturing-of-accutox-cgmp-final-drug-product-optimization-for-its-phase-i-clinical-trial-at-city-of-hope/ 2023-06-16T09:00:00+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/hal-gatewood-OgvqXGL7XO4-unsplash.jpeg https://defencetherapeutics.com/defence-patent-portfolio-at-the-forefront-of-success/ 2023-06-28T16:45:23+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/tim-bogdanov-4uojMEdcwI8-unsplash.jpeg https://defencetherapeutics.com/wp-content/uploads/2023/06/Screen-Shot-2023-06-28-at-9.41.41-AM.png https://defencetherapeutics.com/defence-and-viewpoint-with-dennis-quaid-join-forces-to-explore-breakthrough-in-biotechnology/ 2023-07-04T16:37:11+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/national-cancer-institute-L7en7Lb-Ovc-unsplash.jpeg https://defencetherapeutics.com/defence-successfully-completes-the-first-milestone-of-its/ 2023-07-18T16:34:03+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/thisisengineering-raeng-bcqDxjddPGk-unsplash.jpeg https://defencetherapeutics.com/defences-innovative-therapeutics-are-featured-on-viewpoint-with-dennis-quaid/ 2023-09-08T16:40:11+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/ian-dooley-TevqnfbI0Zc-unsplash-scaled.jpeg https://defencetherapeutics.com/defences-broad-and-versatile-accum-technology-platform-focus-on-cancer-therapeutics/ 2023-09-12T18:48:14+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/defence-to-collaborate-with-native-ads-for-marketing-campaign/ 2023-09-25T16:57:11+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Stocksy_txpa55392e5ims200_Medium_2145911.jpg https://defencetherapeutics.com/defences-accum-mrna-lipid-nanoparticles-elicit-antibody-response-2x-stronger-than-standard-mrna-vaccines/ 2023-09-25T18:05:21+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/mufid-majnun-cM1aU42FnRg-unsplash.jpeg https://defencetherapeutics.com/2585-2/ 2023-10-10T16:24:46+00:00 https://defencetherapeutics.com/wp-content/uploads/2020/11/leadership-universitys.jpg https://defencetherapeutics.com/defence-to-present-three-of-its-leading-products-at-the-upcoming-festival-of-biologics-in-basel-switzerland/ 2023-10-11T16:56:05+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/10/andreas-m-xu5FvpWvSk-unsplash.jpeg https://defencetherapeutics.com/delivery-of-encapsulated-accutoxtm-chitosan-nanoparticles-triggers-complete-tumor-regression-in-animals-with-pre-estabslihed-solid-lymphoma/ 2023-10-17T16:14:53+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/10/alexander-andrews-fsH1KjbdjE8-unsplash.jpeg https://defencetherapeutics.com/defences-novel-accutoxtm-continues-to-surprise-on-results-against-cancer/ 2023-10-18T17:22:22+00:00 https://defencetherapeutics.com/wp-content/uploads/2020/11/leadership-universitys.jpg https://defencetherapeutics.com/defences-successful-submission-of-an-investigational-new-drug-ind-application-for-accutox-as-an-injectable-anticancer-treatment-for-solid-tumors/ 2023-11-14T18:42:26+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/11/national-cancer-institute-2fyeLhUeYpg-unsplash.jpeg https://defencetherapeutics.com/wp-content/uploads/2023/11/Screen-Shot-2023-11-14-at-10.41.38-AM.png https://defencetherapeutics.com/defence-receives-fda-approval-for-phase-i-clinical-trial-targeting-solid-cancer-tumors-with-accutox/ 2023-12-12T19:32:02+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/tim-bogdanov-4uojMEdcwI8-unsplash.jpeg https://defencetherapeutics.com/defences-accutox-impairs-lung-cancer-growth/ 2024-01-10T18:35:32+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/national-cancer-institute-p1zy6izFI0M-unsplash.jpeg https://defencetherapeutics.com/wp-content/uploads/2024/01/Screen-Shot-2024-01-10-at-10.33.16-AM.png https://defencetherapeutics.com/defence-financing/ 2024-01-22T17:32:16+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-completes-1st-tranche-of-financing/ 2024-02-01T20:10:54+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/02/rock-staar-NzIV4vOBA7s-unsplash.jpeg https://defencetherapeutics.com/defence-announces-peer-reviewed-publication-on-accum-e7-anti-cancer-vaccine-in-cancer-science-journal-and-financing-update/ 2024-02-29T23:00:27+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/02/fusion-medical-animation-rnr8D3FNUNY-unsplash.jpeg https://defencetherapeutics.com/la-plateforme-de-technologie-etendue-et-polyvalente-accum-de-defence-se-concentre-sur-les-produits-therapeutiques-contre-le-cancer/ 2024-03-04T17:34:49+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/defence-therapeutics-complete-la-premiere-tranche-de-son-financement/ 2024-03-04T17:46:27+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/02/rock-staar-NzIV4vOBA7s-unsplash.jpeg https://defencetherapeutics.com/defence-financing-2/ 2024-03-04T17:46:57+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/accutox-de-defence-reduit-la-croissance-du-cancer-du-poumon/ 2024-03-04T17:47:22+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/thisisengineering-raeng-bcqDxjddPGk-unsplash.jpeg https://defencetherapeutics.com/wp-content/uploads/2024/01/Screen-Shot-2024-01-10-at-10.33.16-AM.png https://defencetherapeutics.com/defence-recoit-lapprobation-de-la-fda-aux-etats-unis-pour-lessai-clinique-de-phase-i-avec-accutox-ciblant-les-tumeurs-cancereuses-solides/ 2024-03-04T17:47:47+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/hal-gatewood-OgvqXGL7XO4-unsplash.jpeg https://defencetherapeutics.com/defence-presentera-trois-de-ses-produits-phares-au-prochain-festival-of-biologics-a-bale-en-suisse/ 2024-03-04T17:48:11+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Stocksy_txpa55392e5ims200_Medium_2145911.jpg https://defencetherapeutics.com/les-nanoparticules-lipidiques-accum-arnm-de-defence-provoquent-une-reponse-des-anticorps-deux-fois-plus-puissante-que-les-vaccins-a-arnm-standard/ 2024-03-04T17:48:32+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/defence-sassocie-a-native-ads-pour-sa-campagne-de-marketing/ 2024-03-04T17:48:59+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-awarded-broad-u-s-patent-covering-its-pioneering-cancer-killing-accutox-technology/ 2024-03-04T20:58:09+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_333511912-scaled.jpeg https://defencetherapeutics.com/defence-completes-2nd-tranche-of-financing/ 2024-03-26T13:41:52+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/defences-successful-results-on-its-accutox-anti-cancer-armtm-vaccine-creates-a-potent-second-generation-anti-cancer-arm-002tm-vaccine/ 2024-03-26T15:54:02+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_321710772-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-announces-warrant-terms-amendment/ 2024-04-08T18:42:29+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/defence-therapeutics-signs-with-german-based-fms-consult-gmbh-for-financing-strategy-to-support-defence-pipeline-growth/ 2024-04-23T16:11:48+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/04/ben-thai-dLkHUpl_wuY-unsplash.jpeg https://defencetherapeutics.com/defences-accutox-anti-cancer-arm-002-vaccine-exhibits-potent-antigen-presentation/ 2024-04-23T16:14:08+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Stocksy_txpa55392e5ims200_Medium_2145911.jpg https://defencetherapeutics.com/pancreactic-cancer-succesful-trial-against-pancreatic-cancer-with-defences-arm-002-anti-cancer-vaccine/ 2024-05-01T21:30:25+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/hal-gatewood-OgvqXGL7XO4-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-strengthens-and-expands-global-patent-protection-on-key-technologies/ 2024-05-14T18:48:49+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/05/alexander-andrews-fsH1KjbdjE8-unsplash.jpeg https://defencetherapeutics.com/defences-accutox-published-in-the-prestigious-journal-of-translational-medicine-its-peer-study-with-preclinical-data-on-accutox-as-an-anti-cancer-molecule/ 2024-06-06T17:11:05+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/06/national-cancer-institute-LnvCEXQwC-o-unsplash.jpeg https://defencetherapeutics.com/defence-to-participate-to-2024-society-of-nuclear-medicine-and-molecular-imaging-annual-meeting-in-toronto-on-june-11-2024/ 2024-06-11T17:22:14+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_334242430-scaled.jpeg https://defencetherapeutics.com/defences-arm-x-anti-cancer-vaccine-inhibits-growth-of-pre-established-ovarian-cancer-resulting-in-complete-responses-in-treated-animals/ 2024-06-25T16:20:29+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/wp-content/uploads/2024/06/Screen-Shot-2024-06-25-at-9.16.58-AM.png https://defencetherapeutics.com/wp-content/uploads/2024/06/Screen-Shot-2024-06-25-at-9.16.58-AM.png https://defencetherapeutics.com/defences-accutox-boosts-and-synergizes-with-immune-checkpoint-inhibitors/ 2024-07-02T16:12:50+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/07/luke-stackpoole-BIzowjmRc_g-unsplash.jpg https://defencetherapeutics.com/defence-receives-no-objection-letter-from-health-canada-for-phase-i-trial-of-its-accum-002-accutox-as-an-anti-cancer-molecule-in-patients-with-melanoma/ 2024-07-08T15:55:46+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/07/sheng-hu-LEcREeDqi0I-unsplash.jpg https://defencetherapeutics.com/defence-therapeutics-granted-cnri-h-from-the-canadian-nuclear-laboratories-to-accelerate-the-development-of-its-radio-immuno-conjugates-program/ 2024-07-24T16:43:43+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/11/national-cancer-institute-2fyeLhUeYpg-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-collaboration-agreement-with-orano-to-develop-the-next-generation-of-targeted-radio-immunotherapy-for-cancer-advances/ 2024-08-13T23:33:03+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/ian-dooley-TevqnfbI0Zc-unsplash-scaled.jpeg https://defencetherapeutics.com/defence-investigates-the-application-of-the-accum-hydrogel-technology-to-deliver-glp-1-in-order-to-increase-the-treatment-efficacy-of-diabetes-and-weight-loss/ 2024-08-26T18:28:55+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Stocksy_txpa55392e5ims200_Medium_2145911.jpg https://defencetherapeutics.com/defences-corporate-updates-arranges-financing/ 2024-09-30T20:01:42+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/investors-image.jpg https://defencetherapeutics.com/defence-therapeutics-completes-1st-tranche-of-financing-2/ 2024-11-01T15:41:48+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_334242430-scaled.jpeg https://defencetherapeutics.com/defence-announces-extension-of-private-placement-continues-development-of-its-radiopharmaceuticals-and-adc-programs/ 2024-11-05T17:53:09+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/07/luke-stackpoole-BIzowjmRc_g-unsplash.jpg https://defencetherapeutics.com/defence-announces-radiopharmaceutical-expert-svetlana-selivanova-joins-board-of-directors/ 2024-11-14T16:57:28+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/ian-dooley-TevqnfbI0Zc-unsplash-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-announces-securities-for-debenture-financing/ 2024-11-15T21:34:49+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/06/tim-bogdanov-4uojMEdcwI8-unsplash.jpeg https://defencetherapeutics.com/defence-announces-closing-of-securities-for-debenture-financing/ 2024-11-25T20:45:20+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/04/ben-thai-dLkHUpl_wuY-unsplash.jpeg https://defencetherapeutics.com/defence-announces-molecular-and-antibody-research-expert-dr-elias-theodorou-joins-its-board-of-directors/ 2024-12-28T21:32:51+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/ian-dooley-TevqnfbI0Zc-unsplash-scaled.jpeg https://defencetherapeutics.com/defence-announces-dr-maxime-parisotto-as-cso-director-of-science-and-business-development/ 2024-12-28T21:32:57+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/thisisengineering-raeng-bcqDxjddPGk-unsplash.jpeg https://defencetherapeutics.com/defence-arranges-financing/ 2025-01-03T21:20:53+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/04/ben-thai-dLkHUpl_wuY-unsplash.jpeg https://defencetherapeutics.com/defence-fortifies-patent-portfolio/ 2025-01-06T21:23:37+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/07/luke-stackpoole-BIzowjmRc_g-unsplash.jpg https://defencetherapeutics.com/defence-to-connect-with-industry-leaders-and-potential-partners-during-the-jp-morgan-healthcare-conference-in-san-francisco-plans-to-expand-the-next-generation-of-radio-immuno-conjugates-in-2025/ 2025-01-13T17:28:33+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/investors-image.jpg https://defencetherapeutics.com/defence-closes-second-tranche-of-fully-subscribed-financing-totaling-4-2-million/ 2025-02-05T21:26:56+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/mufid-majnun-cM1aU42FnRg-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-to-attend-bio-international-convention-in-boston-june-2025/ 2025-05-29T20:07:37+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/04/ben-thai-dLkHUpl_wuY-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-receives-uspto-allowance-for-patent-application-covering-next-gen-adc-technology/ 2025-06-10T17:04:28+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_333511912-scaled.jpeg https://defencetherapeutics.com/defences-accum-technology-with-adc-and-radiopharmaceutical-programs-target-cancer/ 2025-07-14T16:22:35+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_321710772-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-announces-debenture-units-financing/ 2025-08-25T17:41:35+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Stocksy_txpa55392e5ims200_Medium_2145911.jpg https://defencetherapeutics.com/defence-therapeutics-engages-dr-amie-phinney-as-strategy-business-advisor-to-guide-next-phase-of-growth/ 2025-09-12T17:05:38+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_334242430-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-appoints-dr-amie-phinney-as-director/ 2025-09-16T09:28:06+00:00 https://defencetherapeutics.com/defence-therapeutics-appoints-dr-amie-phinney-as-director-2/ 2025-09-16T17:42:58+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/04/ben-thai-dLkHUpl_wuY-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-completes-fully-subscribed-debenture-units-financing-of-2000000/ 2025-09-16T17:44:02+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/08/acuum-technology-defence-therapeutic-hero-scaled.webp https://defencetherapeutics.com/defences-director-strategy-business-advisor-dr-amie-phinney-discusses-the-accum-platform-on-money-talk-radio-with-ellis-martin/ 2025-09-24T22:48:30+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/ian-dooley-TevqnfbI0Zc-unsplash-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-appoints-dr-mark-lambermon-as-head-of-quality-and-operations/ 2025-10-02T20:30:23+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/mufid-majnun-cM1aU42FnRg-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-to-attend-cphi-worldwide-in-frankfurt-october-28-30-2025/ 2025-10-06T17:51:10+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/08/acuum-technology-defence-therapeutic-hero-scaled.webp https://defencetherapeutics.com/defence-to-present-new-scientific-data-on-its-adc-enhancing-accum-technology-at-the-world-adc-conference-in-san-diego-usa-november-4-5-2025/ 2025-10-23T19:11:51+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_194483477-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-demonstrates-strong-preclinical-in-vivo-efficacy-results-evaluating-accum-kadcyla-in-breast-cancer-models/ 2025-11-07T19:56:25+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/02/fusion-medical-animation-rnr8D3FNUNY-unsplash.jpeg https://defencetherapeutics.com/wp-content/uploads/2025/11/Screenshot-2025-11-07-at-11.55.30-AM.png https://defencetherapeutics.com/wp-content/uploads/2025/11/Screenshot-2025-11-07-at-11.55.30-AM.png https://defencetherapeutics.com/defence-announces-successful-presentation-at-the-world-adc-conference-in-san-diego-and-plans-to-expand-evaluation-of-accum-in-commercial-and-pipeline-adcs/ 2025-11-07T19:58:14+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/national-cancer-institute-L7en7Lb-Ovc-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-to-build-adc-drug-delivery-powerhouse-using-its-proprietary-accum-technology/ 2025-11-21T17:28:56+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/07/luke-stackpoole-BIzowjmRc_g-unsplash.jpg https://defencetherapeutics.com/defence-therapeutics-announces-convertible-debenture-conversion/ 2025-11-24T18:33:50+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/05/AdobeStock_333511912-scaled.jpeg https://defencetherapeutics.com/defence-therapeutics-announces-formation-of-scientific-advisory-board-to-guide-advancement-of-accum-enhanced-antibody-drug-conjugate-programs/ 2025-12-04T17:51:02+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/08/investors-image-2.jpg https://defencetherapeutics.com/defence-therapeutics-announces-agm-results-and-provides-corporate-updates/ 2025-12-11T20:34:51+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-sharpens-strategic-focus-on-precision-drug-delivery-to-unlock-the-full-potential-of-cancer-biologics/ 2026-01-21T17:06:29+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/09/Screen-Shot-2023-09-12-at-11.47.45-AM.png https://defencetherapeutics.com/defence-therapeutics-expands-collaboration-with-canadian-nuclear-laboratories-to-accelerate-its-proprietary-radiopharmaceutical-pipeline/ 2026-01-28T19:53:16+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutic-lab.webp https://defencetherapeutics.com/defence-therapeutics-to-present-at-the-world-adc-europe-2026-showcasing-accum-precision-intracellular-drug-delivery-platform/ 2026-02-04T16:30:14+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/iStock-1494221087-scaled.jpg https://defencetherapeutics.com/defence-therapeutics-aligns-accum-adc-strategy-through-multidisciplinary-scientific-advisory-board/ 2026-02-10T16:30:37+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutic-partnerships.jpg https://defencetherapeutics.com/defence-therapeutics-to-showcase-accum-platform-at-key-international-industry-events-in-march/ 2026-03-02T16:30:02+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/09/protais-benjamin-mugenzi-AniWhid1Gu0-unsplash-scaled.jpg https://defencetherapeutics.com/defence-therapeutics-announces-private-placement-of-units-for-proceeds-of-up-to-11-million/ 2026-03-03T17:40:40+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutics-about-us.jpg https://defencetherapeutics.com/defence-therapeutics-announces-closing-of-private-placement-of-units-for-gross-proceeds-of-9595000/ 2026-03-09T17:38:42+00:00 https://defencetherapeutics.com/wp-content/uploads/2023/07/thisisengineering-raeng-bcqDxjddPGk-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-announces-warrant-terms-amendment-2/ 2026-03-21T21:40:59+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutics-about-us.jpg https://defencetherapeutics.com/defence-therapeutics-announces-grant-of-restricted-stock-units/ 2026-04-27T17:58:54+00:00 https://defencetherapeutics.com/wp-content/uploads/2024/01/stephen-h-EgeN-rF6wk4-unsplash.jpeg https://defencetherapeutics.com/defence-therapeutics-enhances-in-house-adc-development-platform-with-expanded-analytical-and-cellular-testing-capabilities/ 2026-05-19T16:12:28+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/08/acuum-tech-defence-therapeutic-hero-scaled.webp https://defencetherapeutics.com/defence-therapeutics-strengthens-its-scientific-advisory-board-with-the-appointment-of-dr-sarkis-meterissian/ 2026-06-01T16:35:07+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutics-about-us.jpg https://defencetherapeutics.com/defence-therapeutics-appoints-antibody-drug-conjugates-pioneer-dr-john-lambert-to-its-board-of-directors/ 2026-06-01T16:38:07+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/09/cdc-OZcQIhidMTw-unsplash_-scaled.jpg https://defencetherapeutics.com/defence-therapeutics-appoints-seasoned-biopharmaceutical-executive-dr-john-beaver-to-its-board-of-directors/ 2026-06-03T19:31:36+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutic-partnerships.jpg https://defencetherapeutics.com/defence-therapeutics-to-participate-in-bio-international-convention-2026-next-week-for-strategic-partnership-discussions/ 2026-06-17T16:57:53+00:00 https://defencetherapeutics.com/wp-content/uploads/2025/09/protais-benjamin-mugenzi-AniWhid1Gu0-unsplash-scaled.jpg https://defencetherapeutics.com/defence-therapeutics-opens-new-office-in-hamilton-to-expand-its-accum-radiopharmaceutical-platform/ 2026-07-08T12:00:14+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutics-partnership-pharma.jpg https://defencetherapeutics.com/defence-therapeutics-appoints-dr-amie-phinney-as-president-and-chief-executive-officer/ 2026-08-04T15:50:04+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/08/Screenshot-2026-08-04-at-8.43.54-AM.png https://defencetherapeutics.com/defence-therapeutics-strengthens-radiopharmaceutical-leadership-with-appointment-of-dr-ryan-simms-as-chief-operating-officer-and-head-of-radiopharmaceutical-programs/ 2026-08-19T20:01:37+00:00 https://defencetherapeutics.com/wp-content/uploads/2026/01/defence-therapeutic-partnerships.jpg